Announcements Trials

Browse Landscape

Phase

Status

Unknown 4 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 37 Breast Neoplasms 26 Prostatic Neoplasms 22 Stomach Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 12 Lung Neoplasms 11 Neoplasms 10 Urinary Bladder Neoplasms 8 Head and Neck Neoplasms 8 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 7 Carcinoma, Squamous Cell 6 Non-Muscle Invasive Bladder Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Transitional Cell 5 Adenocarcinoma 5 Oropharyngeal Neoplasms 4 Sarcoma 3 Prostatic Neoplasms, Castration-Resistant 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Esophageal Squamous Cell Carcinoma 3 Endometrial Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Vaccinia 2 Recurrence 2 Peritoneal Neoplasms 2 Metastatic Castration-Resistant Prostate Cancer 2 Melanoma 2

Interventions

Drug Therapy 4 Pemetrexed 3 Carboplatin 3 osimertinib 2 Radiotherapy 2 toripalimab 1 tislelizumab 1 sugemalimab 1 spartalizumab 1 sintilimab 1 pembrolizumab 1 cemiplimab 1 aflutinib 1 Vinorelbine 1 Radiosurgery 1 Platinum 1 Paclitaxel 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × NSCLC × Docetaxel × Clear all

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡